Einstein Experts

Search Results

You searched for "Type 2 diabetes"

5 results found

Jill P. Crandall, M.D.

Jill P. Crandall, M.D.

Professor, Clinical Medicine (Endocrinology), Einstein

Director, Diabetes Clinical Trials Unit, Einstein

Attending Physician, Montefiore Medical Center

DiabetesType 2 diabetesDiabetes prevention

Clinical TrialsPrediabetesResveratrol

An expert in diabetes prevention, Dr. Crandall is a principal investigator in the NIH-funded Diabetes Prevention Program Outcomes Study, which showed that sustaining weight loss or taking an anti-diabetic drug can stave off type 2 diabetes in people at high risk for the disease. The American Diabetes Association recently funded Dr. Crandall to study whether the wine ingredient resveratrol can prevent diabetes in patients with prediabetes. read more...

 

Judith Wylie-Rosett, Ed.D.

Judith Wylie-Rosett, Ed.D.

Professor, Epidemiology & Population Health (Health Promotion and Nutrition Research)

Professor, Medicine (Endocrinology)

Division Head, Health Promotion and Nutritional Research, Department of Epidemiology & Population Health

NutritionObesityWeight management

Behavior modificationType 2 diabetes

Dr. Wylie-Rosett’s research focuses on nutrition’s role in preventing and controlling chronic diseases—particularly diseases such as type 2 diabetes and heart disease in which obesity is an important risk factor.  She is associate editor of the journal Diabetes Care and author of The Complete Weight Loss Workbook. Dr. Wylie-Rosett has helped the American Diabetes Association and American Heart Association develop nutrition-related recommendations and position statements. read more...

 

Nir Barzilai, M.D.

Nir Barzilai, M.D.

Professor, Medicine (Endocrinology)

Director, Institute for Aging Research

Director, Nathan Shock Center of Excellence in the Basic Biology of Aging

Ingeborg and Ira Leon Rennert Chair of Aging Research

AgingBiology of agingLongevity genes

Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. Dr. Barzilai has been profiled by major outlets, including The New York Times and PBS’ “NOVA scienceNow.” read more...

 

Meredith A. Hawkins, M.D.

Meredith A. Hawkins, M.D.

Professor, Medicine (Endocrinology), Einstein

Director, Global Diabetes Institute, Einstein

Attending Physician, Medicine, Montefiore Medical Center

DiabetesGlobal diabetesType 2 diabetes

Malnutrition diabetesGlobal health

Dr. Hawkins specializes in diabetes, with a particular emphasis on the dramatic rise of the disease worldwide. She has traveled the globe investigating diabetes since 1996 and is the founding director of the Global Diabetes Institute (GDI) at Einstein, which conducts diabetes education and training for healthcare workers in South and Central America, Eastern Europe, Africa and Asia. read more...

 

John M. Greally, M.B.,B.Ch., Ph.D.

John M. Greally, M.B.,B.Ch., Ph.D.

Chief, Division of Computational Genetics, Einstein

Director, Center for Epigenomics, Einstein

The Ruth L. and David S. Gottesman Faculty Scholar for Epigenomics, Einstein

Attending Physician, Pediatrics, The Children's Hospital at Montefiore

GeneticsEpigenetics/epigenomics

Dr. Greally began his career as a pediatrician who subspecialized in clinical genetics, seeing patients with genetic syndromes, birth defects and developmental problems. Now, Dr. Greally seeks to understand how genetic disease is caused not by DNA mutations, but due to abnormalities in how genes are switched off and on – a field known as epigenomics.  read more...